3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
3
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
5
Menorrhagia
1
Endometriosis
1
Interventions
estradiol, norethindrone drug combination
9
elagolix
7
Estradiol
7
asoprisnil
6
Uterine Artery Embolization
5
Norethindrone Acetate
5
relugolix
4
Uterine Myomectomy
3
linzagolix
2
Tranexamic Acid
2
ziprasidone
1
vilaprisan
1
ulipristal
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Radiofrequency Ablation
1
Progesterone
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Menorrhagia
×
vilaprisan
×
Clear all
NCT02465814
2016-11-22
ASTEROID 2
Bayer
Phase 2
Completed
120 enrolled